Prasugrel/Clopidogrel Maintenance Dose Washout Study
Recovery of Platelet Function Following Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Subjects With Stable Coronary Disease
Sponsor: Daiichi Sankyo
This PHASE4 trial investigates Coronary Artery Disease and is currently completed. Daiichi Sankyo leads this study, which shows 10 recorded versions since 2010 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2024 — Jul 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Mar 2024 [monthly]
Completed PHASE4
-
Jun 2021 — Sep 2021 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Sep 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Feb 2017 — Sep 2017 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Feb 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Daiichi Sankyo
For direct contact, visit the study record on ClinicalTrials.gov .